18 related articles for article (PubMed ID: 2433427)
1. The effects of soman on the electrical properties and excitability of bullfrog sympathetic ganglion neurones.
Heppner TJ; Fiekers JF
Br J Pharmacol; 1991 Aug; 103(4):1985-91. PubMed ID: 1912986
[TBL] [Abstract][Full Text] [Related]
2. Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates.
Tattersall JE
Br J Pharmacol; 1990 Oct; 101(2):349-57. PubMed ID: 1701677
[TBL] [Abstract][Full Text] [Related]
3. Interactions of edrophonium, physostigmine and methanesulfonyl fluoride with the snake end-plate acetylcholine receptor-channel complex.
Fiekers JF
J Pharmacol Exp Ther; 1985 Sep; 234(3):539-49. PubMed ID: 2411911
[TBL] [Abstract][Full Text] [Related]
4. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex.
Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX
Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099
[TBL] [Abstract][Full Text] [Related]
5. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
6. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
[TBL] [Abstract][Full Text] [Related]
8. Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.
Rao KS; Aracava Y; Rickett DL; Albuquerque EX
J Pharmacol Exp Ther; 1987 Jan; 240(1):337-44. PubMed ID: 2433427
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
